New CMS rule promotes payer drug price negotiations based on clinical outcomes
(By Maia Anderson for Becker’s Hospital Review ) CMS issued a proposed rule June 17 that would make it easier
Read More
Part D/Prescription Drugs
US appeals court strikes down HHS rule requiring drug prices in TV ads
(By Maia Anderson for Becker’s Hospital Review ) A U.S. appeals court upheld a ruling June 16 that struck down
Read MoreEarly Results Show Benefit Of Steroid For Very Sick COVID-19 Patients
(By Joe Palca for NPR) A low-cost anti-inflammatory drug appears to reduce the risk of death in patients with COVID-19.
Read MoreMedicare enrollment periods: when to sign up
(Source - www.medicare.gov/blog) It’s important for you to know when to sign up for Medicare or when to join a
Read More6 recent drug, device recalls
(By Maia Anderson for Becker’s Hospital Review ) Medical device and drug recalls, whether voluntary or mandated by the FDA,
Read MoreStates sue 26 generic drugmakers, accused of fixing prices since 2016
(By Maia Anderson for Becker’s Hospital Review ) All 50 states filed a lawsuit June 10 accusing 26 drugmakers and
Read MoreLife changing events that can lower your “income related monthly adjusted amount” (IRMAA)
Many Medicare beneficiaries believe that everyone pays the same amount for their Medicare Parts B and D, but that’s not
Read MoreHow Could the Price of Remdesivir Impact Medicare Spending for COVID-19 Patients?
(Juliette Cubanski, Karyn Schwartz, and Tricia Neuman for Kaiser Family Foundation) On May 1, 2020, the Food and Drug Administration
Read MoreOptumRx: The 3 drugs that will have the biggest impact on payers, patients in 2020
(By Maia Anderson for Becker’s Hospital Review ) OptumRx, the pharmacy benefit unit of UnitedHealth Group, released a list of
Read MoreInsulin Costs and Coverage in Medicare Part D
(By Juliette Cubanski, Tricia Neuman, Sarah True, and Anthony Damico for Kaiser Family Foundation) In May 2020, the Trump Administration
Read More